Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial

Joshua M. Hare, Joel E. Fishman, Gary Gerstenblith, Darcy L. DiFede Velazquez, Juan P. Zambrano, Viky Y. Suncion, Melissa Tracy, Eduard Ghersin, Peter V. Johnston, Jeffrey A. Brinker, Elayne Breton, Janice Davis-Sproul, Ivonne H. Schulman, John Byrnes, Adam M. Mendizabal, Maureen H. Lowery, Didier Rouy, Peter Altman, Cheryl Wong Po Foo, Phillip RuizAlexandra Amador, Jose Da Silva, Ian K. McNiece, Alan W. Heldman

Research output: Contribution to journalArticlepeer-review

848 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences